Value Health. 2022;25(12):2028-2033.
DOI of original article: 10.1016/j.jval.2022.04.1732
There was an error in Table 1 of the published article in which row 6 was inadvertently omitted. The complete, corrected version of Table 1 is shown below:
Table 1Key parameters for a cost-benefit analysis.
| No. | Parameter | Value |
|---|---|---|
| 1 | Economic value of a year in good health | $150 000 |
| 2 | Real interest rate (ie, nominal interest rate minus inflation; used to discount future costs and benefits) | 3%/year |
| 3 | Quality of life (assuming good health = 1.0) | 0.52 (while receiving dialysis therapy) |
| 4 | 0.75 (after transplant) | |
| 5 | Percentage of costs of patients with kidney failure paid by taxpayers (federal and state) | 79% |
| 6 | Cost for all medical care while receiving maintenance dialysis therapy per year | $114 000 |
| 7 | Cost of a transplant procedure (including organ acquisition charge) per event | $133 000 |
| 8 | Cost of all medical care for a functioning graft (including medications) per year | $34 000 |
| 9 | Cost of kidney graft failure per event | $82 000 |
| 10 | Half-life of first kidney transplant (due to graft failure alone, not patient death) | 32.8 years |
| 11 | Average age at which 50% of patients with newly diagnosed kidney failure with the longest life expectancies would receive first transplants | 53.8 years |
Note. Sources for all parameters are detailed in Appendix Supplement 3 in Supplemental Materials found at https://doi.org/10.1016/j.jval.2022.04.1732.
The online version of the article has been updated to reflect this change.
Article info
Publication history
Published online: January 06, 2023
Publication stage
In Press Corrected ProofIdentification
Copyright
© 2022 International Society for Pharmacoeconomics and Outcomes Research, Inc. Published by Elsevier Inc. All rights reserved.
User license
Creative Commons Attribution – NonCommercial – NoDerivs (CC BY-NC-ND 4.0) | How you can reuse 
Elsevier's open access license policy
Creative Commons Attribution – NonCommercial – NoDerivs (CC BY-NC-ND 4.0)
Permitted
For non-commercial purposes:
- Read, print & download
- Redistribute or republish the final article
- Text & data mine
- Translate the article (private use only, not for distribution)
- Reuse portions or extracts from the article in other works
Not Permitted
- Sell or re-use for commercial purposes
- Distribute translations or adaptations of the article
Elsevier's open access license policy
